Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
18.10
+0.53 (3.02%)
At close: Nov 4, 2024, 4:00 PM
17.26
-0.84 (-4.64%)
After-hours: Nov 4, 2024, 4:04 PM EST
Travere Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for TVTX stock have an average target of 22.69, with a low estimate of 10 and a high estimate of 41. The average target predicts an increase of 25.36% from the current stock price of 18.10.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TVTX stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 4 | 4 |
| Buy | 5 | 5 | 4 | 3 | 6 | 6 |
| Hold | 5 | 5 | 6 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Scotiabank | Scotiabank | Buy Maintains $23 → $27 | Buy | Maintains | $23 → $27 | +49.17% | Nov 1, 2024 |
| Barclays | Barclays | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +10.50% | Nov 1, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $9 → $27 | Hold → Buy | Upgrades | $9 → $27 | +49.17% | Oct 21, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $23 | Buy | Initiates | $23 | +27.07% | Oct 16, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $20 → $40 | Buy | Maintains | $20 → $40 | +120.99% | Oct 11, 2024 |
Financial Forecast
Revenue This Year
228.91M
from 145.24M
Increased by 57.61%
Revenue Next Year
355.02M
from 228.91M
Increased by 55.09%
EPS This Year
-3.80
from -1.50
EPS Next Year
-1.39
from -3.80
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 251.2M | 567.4M | 757.0M | ||
| Avg | 228.9M | 355.0M | 506.5M | ||
| Low | 201.4M | 251.9M | 343.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 72.9% | 147.9% | 113.2% | ||
| Avg | 57.6% | 55.1% | 42.7% | ||
| Low | 38.7% | 10.0% | -3.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.85 | 1.61 | 2.73 | ||
| Avg | -3.80 | -1.39 | 0.22 | ||
| Low | -4.43 | -2.29 | -0.93 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.